Cargando…
Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727992/ https://www.ncbi.nlm.nih.gov/pubmed/32971709 http://dx.doi.org/10.4103/ijo.IJO_1799_20 |
| _version_ | 1783621172897775616 |
|---|---|
| author | Au, Sunny Chi Lik |
| author_facet | Au, Sunny Chi Lik |
| author_sort | Au, Sunny Chi Lik |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7727992 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77279922020-12-11 Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 Au, Sunny Chi Lik Indian J Ophthalmol Letters to the Editor Wolters Kluwer - Medknow 2020-10 /pmc/articles/PMC7727992/ /pubmed/32971709 http://dx.doi.org/10.4103/ijo.IJO_1799_20 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to the Editor Au, Sunny Chi Lik Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 |
| title | Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 |
| title_full | Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 |
| title_fullStr | Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 |
| title_full_unstemmed | Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 |
| title_short | Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19 |
| title_sort | anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under covid-19 |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727992/ https://www.ncbi.nlm.nih.gov/pubmed/32971709 http://dx.doi.org/10.4103/ijo.IJO_1799_20 |
| work_keys_str_mv | AT ausunnychilik antivascularendothelialgrowthfactortreatmentregimenspreferencebychoroidalneovascularizationpatientsundercovid19 |